In that 2021 paper, they reported that after 13 years of follow-up, HRT did not increase the risk of venous thromboembolism or stroke. But in 2023, they said that it did increase the risk of thromboembolism and stroke and so, they concluded, “vasomotor symptoms should only be treated if they are bothersome.”